These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6035089)

  • 1. Alteration of oral digitoxin toxicity and its in vitro binding by cholestyramine.
    Saral R; Spratt JL
    Arch Int Pharmacodyn Ther; 1967 May; 167(1):10-8. PubMed ID: 6035089
    [No Abstract]   [Full Text] [Related]  

  • 2. Interruption of the enterohepatic circulation of digitoxin by cholestyramine. I. Protection against lethal digitoxin intoxication.
    Caldwell JH; Greenberger NJ
    J Clin Invest; 1971 Dec; 50(12):2626-37. PubMed ID: 5129314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of cholestyramine in three patients with beta-acetyldigoxin, beta-methyldigoxin and digitoxin intoxication.
    Kuhlmann J
    Int J Clin Pharmacol Ther Toxicol; 1984 Oct; 22(10):543-8. PubMed ID: 6511130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of cholestyramine resin in the treatment of digitoxin toxicity.
    Cady WJ; Rehder TL; Campbell J
    Am J Hosp Pharm; 1979 Jan; 36(1):92-4. PubMed ID: 758792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interruption of the enterohepatic circulation of digitoxin by cholestyramine. II. Effect on metabolic disposition of tritium-labeled digitoxin and cardiac systolic intervals in man.
    Caldwell JH; Bush CA; Greenberger NJ
    J Clin Invest; 1971 Dec; 50(12):2638-44. PubMed ID: 5129315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the differential influence of acetylation of steroidal architecture and sugar molecules upon the oral toxicity of cardiac glycosides].
    Förster W; Guhlke I; Herrmann R; Krömer G
    Arch Int Pharmacodyn Ther; 1966 Jan; 159(1):1-7. PubMed ID: 5918760
    [No Abstract]   [Full Text] [Related]  

  • 7. Some cyclic ketals and acetals of digitoxin, digoxin, and ouabain.
    Ishaq KS; Gisvold O
    J Pharm Sci; 1970 Mar; 59(3):412-3. PubMed ID: 5416192
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of cholestyramine resin in digitoxin toxicity.
    Pieroni RE; Fisher JG
    JAMA; 1981 May; 245(19):1939-40. PubMed ID: 7230387
    [No Abstract]   [Full Text] [Related]  

  • 9. [Digitoxin intoxication. Treatment with the steroid-binding resin cholestyramine].
    Qvigstad T; Skare S
    Tidsskr Nor Laegeforen; 1974 Jun; 94(18):1190-1. PubMed ID: 4839994
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholestyramine and spironolactone and their combination in digitoxin elimination.
    Carruthers SG; Dujovne CA
    Clin Pharmacol Ther; 1980 Feb; 27(2):184-7. PubMed ID: 7353337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Affinity of polar digoxin and digitoxin metabolites for digoxin and digitoxin antibodies].
    Flasch H; Heinz N; Petersen R
    Arzneimittelforschung; 1977; 27(3):649-53. PubMed ID: 577438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations of digoxin and digitoxin during digitalization of healthy dogs and dogs with cardiac failure.
    Rick AD; Belpaire FM; Bogaert MG; Mattheeuws D
    Am J Vet Res; 1978 May; 39(5):811-5. PubMed ID: 727580
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cholestyramine for digoxin intoxication].
    Krivoy N; Eisenman A
    Harefuah; 1995 Feb; 128(3):145-7, 199. PubMed ID: 7759003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Digitoxin poisoning: reversing ventricular fibrillation with Fab fragments of anti-digoxin antibody].
    Domart Y; Bismuth C; Schermann JM; Abuaf N; Pontal PG; Baud F; Bolo A; Gailliot M; Fournier PE
    Nouv Presse Med; 1982 Dec; 11(52):3827-30. PubMed ID: 7162976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated doses of activated charcoal and cholestyramine for digitoxin overdose: pharmacokinetic data and urinary elimination.
    Hantson P; Vandenplas O; Mahieu P; Wallemacq P; Hassoun A
    J Toxicol Clin Exp; 1991 Dec; 11(7-8):401-5. PubMed ID: 1841076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of cholestyramine in the treatment of digoxin intoxication.
    Henderson RP; Solomon CP
    Arch Intern Med; 1988 Mar; 148(3):745-6. PubMed ID: 3341874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity correlation of the lethality and central effects of selected cardiac glycosides.
    Lage GL; Spratt JL
    J Pharmacol Exp Ther; 1966 Jun; 152(3):501-8. PubMed ID: 5950891
    [No Abstract]   [Full Text] [Related]  

  • 18. [Toxic serum digitoxin and digoxin concentrations (author's transl)].
    Hiramori K; Takahashi S; Honda T; Kondo M; Hirosawa K
    Kokyu To Junkan; 1975 Mar; 23(3):257-61. PubMed ID: 1168942
    [No Abstract]   [Full Text] [Related]  

  • 19. Cholestyramine resin in the treatment of digitoxin toxicity.
    Baciewicz AM; Isaacson ML; Lipscomb GL
    Drug Intell Clin Pharm; 1983 Jan; 17(1):57-9. PubMed ID: 6825560
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the characteristics of the binding of cardiac glycosides by plasma proteins].
    Kuschinsky K
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(3):388-98. PubMed ID: 4238724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.